论文部分内容阅读
广州中山大学颜光美教授在2014年10月19日举行的M1病毒研究成果新闻发布会上表示:M1抗癌药物若科研条件顺利,尽量争取用3年时间结束临床前阶段的研究工作,获得一期临床试验的许可证,到时,M1病毒就可以试用在自愿参与试验的患者身上,尽可能地缩短时间。肿瘤单靠一种方式治疗不现实,一定要联合治疗,而M1病毒为肿瘤患者个体化治疗方案提供了可能。M1病毒只不过是治疗肿瘤十八
Zhongshan University, Guangzhou Professor Yan Guangmei on October 19, 2014 at the M1 virus research results press conference said: M1 anti-cancer drugs if the research conditions are good, try to use 3 years to end the preclinical phase of research work, get a The clinical trial license, when the M1 virus can be tested in patients who volunteered to participate in the trial, as much as possible to shorten the time. Cancer treatment by one way unrealistic, we must combine treatment, and M1 virus for individualized treatment of cancer patients may provide the program. The M1 virus is just a cure for tumors